foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

£29m Series B spurs Enterprise Therapeutics’ muco-...

Key learnings:

Read More

JAG Shaw Baker: Readying the life sciences sector ...

Key learnings:

Read More

Overcoming commercialisation challenges in advance...

Learn more about the commercialisation of advanced therapies in the upcomin...

Read More

Brexit: Life Sciences - House of Commons Issues Re...

On 21 March 2018, the UK House of Commons Health and Social Care Committee ...

Read More

Why whistleblowing should be a boardroom issue in ...

Biotech and Money, in partnership with EQS Group, is pleased to announce a ...

Read More

Marks & Clerk: A future-focused approach to intell...

Key learnings:

Read More

Gill Jennings & Every: Asking the right questions ...

Key learnings:

Read More

A spotlight on life sciences option deals  

Key learnings:

Read More

Learn about funding for advanced therapies 

Biotech and Money and Phacilitate are launching a three-part webinar series...

Read More

Webinar Series: Funding, Commercialisation and Mar...

Learn more about the key funding, commercialisation, and market access chal...

Read More

Gallagher: Steering companies through the life sci...

Key learnings:

Read More

Surge in UK pharma and biotech patent filings show...

In its latest annual report and statistical release, the European Patent Of...

Read More

Add Your Response